| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.0059 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.00042 | 1 |